Lux Capital Management related stories
All articles and analysis
DCM leads Series B round for MatterportMatterport said Monday that it has closed $16 million in Series B financing. DCM Ventures led the round with participation from AME Cloud Ventures. Other investors include Lux Capital, Felicis Ventures, Greylock Partners, Navitas Capital, AMD Ventures, Qualcomm Ventures and Rothenberg Ventures. Based in Mountain View, Calif., Matterport develops cloud-based 3D models of interior spaces.
- VC-backed Siluria Technologies promotes two
Siluria Technologies has promoted Rahul Iyer to vice president of corporate development and Gary Koehler to vice president of operations. Siluria is a company that converts natural gas into chemicals and fuels. It is backed by ARCH Venture Partners, The Wellcome Trust, Alloy Ventures, Kleiner Perkins Caufield & Byers, Bright Capital, Altitude Life Science Ventures, Lux Capital and Vulcan Capital.
3D printing revolution reshapes healthcare--VCJ reportSOLS, which focuses on orthotics, is the latest 3D printing startup to secure capital from VCs
3D printing revolution reshapes healthcareSOLS, which focuses on orthotics, is the latest 3D printing startup to secure capital from VCs
- IPO Profile: Cerulean Pharma Inc
Crown Ventures, Lilly Ventures, Lux Capital, Polaris Partners and Venrock as a group own 9.25 million shares worth $64.8 million at the IPO price.
- 3D printing company SOLS Systems raises $6.4 mln
SOLS Systems, a maker of 3D printing technology focused on orthotics, has announced it has raised a $6.4 million round of funding led by Lux Capital. Also participating in the Series A round is new investor Founders Fund as well as existing investors RRE Ventures, Rothenberg Ventures, Felicis Ventures, FundersGuild and Grape Arbor VC. The New York-based company has now raised just over $8.1 million in total funding since it was launched in 2013.
- Kala Pharmaceuticals scores $22.5 mln
Kala Pharmaceuticals said Wednesday that it has closed $22.5 million in Series B financing. Ysios Capital led the round with participation from Crown Venture Fund, Lux Capital, Polaris Partners and Third Rock Ventures. In addition to the funding, Dr. Karen Wagner, a general partner at Ysios Capital, has been added to Kala’s board of directors. Based in Waltham, Mass., Kala Pharmaceuticals is a developer of treatments for ocular diseases.
- VCs launch into new space: VCJ
Welcome to the era of “New Space,” where a small, but growing number of emerging hardware companies – many venture backed – are starting to take over the reins of space exploration as Washington, D.C., and other government agencies worldwide, shift the financial burden to private enterprise, affiliate magazine Venture Capital Journal reports.
VCs launch into new space: VCJWelcome to the era of “New Space,” where a small, but growing number of emerging hardware companies – many venture backed – are starting to take over the reins of space exploration as Washington, D.C., and other government agencies worldwide, shift the financial burden to private enterprise, affiliate magazine Venture Capital Journal reports.
VCs launch into new spaceNew satellites are smaller and less expensive than past generations, as the space industry benefits from advances in smartphone technology